Crocin and crocetin are observed to inhibit amyloid-beta peptide aggression and hold off synaptic loss, bringing about neuroprotection versus Alzheimer's disorder-linked cognitive deterioration. Properly-intended scientific trials should investigate the conflicting benefits of now available i